CVE-2023-38950: ZKTeco BioTime Path Traversal Vulnerability
Affects ZKTeco BioTimeSource CISA KEV
Exploited in the wild · KEV due 9 Jun 2025 · public detection template (Nuclei) · 92% EPSS : apply the vendor's fix or mitigations to ZKTeco BioTime now.
Data as of 10/24/2026, 22:15:59 UTC
- Exploitation
Actively exploited – in CISA KEV since 05/19/2025
- KEV deadline
- 06/09/2025 US federal agencies must patch by this date; a sensible deadline for everyone else.
- EPSS
- 92.4% chance of exploitation in 30 days – higher than 99% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
- Public exploits
- a Nuclei detection templatePublic attack or detection tooling exists; see Public exploits below.
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:NWhat to do
CISA required action
Apply mitigations per vendor instructions, follow applicable BOD 22-01 guidance for cloud services, or discontinue use of the product if mitigations are unavailable.
Public exploits and detection
Nuclei detection templates
Public tooling indexed from Metasploit Framework, Exploit-DB and ProjectDiscovery nuclei-templates. Its existence raises the odds of exploitation; it does not confirm attacks.
Description
ZKTeco BioTime contains a path traversal vulnerability in the iclock API that allows an unauthenticated attacker to read arbitrary files via supplying a crafted payload.
Weaknesses
- CWE-22Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') (opens in a new tab)
Base weaknessLikelihood of exploit: HighCWE Top 25 (2025): #6OWASP Top 10 A01:2025: Broken Access Control (opens in a new tab)
The product uses external input to construct a pathname that is intended to identify a file or directory that is located underneath a restricted parent directory, but the product does not properly neutralize special elements within the pathname that can cause the pathname to resolve to a location that is outside of the restricted directory.